the Federal Minister of health, Jens Spahn hopes for the treatment of lung disease Covid-19 soon, targeted drugs can be used. “There is evidence that certain drugs seem to help,” said the CDU politician in the “picture live”. To this end, studies should be “as soon as possible” done. However, must also be taken: The patient should be protected, because every medicine have side effects. There is also in Germany a number of studies, also to the “old Malaria means” retinal toxicity (active ingredient chloroquine phosphate) of the pharmaceutical and chemicals group Bayer. However, there are also other medications that may help. dpa/Annegret Hilse/Reuters Pool/Reuters the Federal Minister of health, Jens Spahn.
In any case, will be significantly used to be a drug than a vaccine on the market, said Spahn, and is hence in line with many experts. “Vaccine development is challenging. The Malaria drug we have known for years and decades. Since we know the effects and side effects,” said Spahn. These effects and side effects should you weigh now, new for use for the treatment of Coronavirus-related diseases. “The vaccine is more of a question of several months as of a few months.” He did not want to specify but said Spahn, adding: “I would be the happiest Minister of health in the world, if we had in three or six months of a vaccine. But I am also enough of a Realist and enough expert advice to know, it can take twelve months.” Therefore, the policy should not raise false hopes.
Bayer announced on Thursday, to create in Europe, production potential for the drug chloroquine in the fight against lung disease Covid-19. Already in the 1930s, developed a drug for malaria prophylaxis for a few weeks in the conversation, after Tests on cell cultures had shown an inhibition of the proliferation of the novel Coronavirus.
Where is Coronavirus? The real-time map showing the spread of the disease, FOCUS Online/Wochit Where is Coronavirus? The real-time map showing the spread of the disease
FOCUS Online provides you daily with the most important messages directly from the editors. Here you can subscribe to the Newsletter easily and free of charge.
lik, cvh, lau, ufe, fas, ter, sca, beb, pnh, flr/with Agency material